Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Impacts and shortcomings of genetic clustering methods for infectious disease outbreaks.

Poon AF.

Virus Evol. 2016 Oct 20;2(2):vew031. doi: 10.1093/ve/vew031.

2.

Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm3.

Mutembo S, Mutanga JN, Musokotwane K, Alisheke L, Whalen CC.

BMC Infect Dis. 2016 Oct 17;16(1):572.

3.

Housing and tuberculosis in an Inuit village in northern Quebec: a case-control study.

Khan FA, Fox GJ, Lee RS, Riva M, Benedetti A, Proulx JF, Jung S, Hornby K, Behr MA, Menzies D.

CMAJ Open. 2016 Sep 16;4(3):E496-E506.

4.

Identifying cost-effective dynamic policies to control epidemics.

Yaesoubi R, Cohen T.

Stat Med. 2016 Dec 10;35(28):5189-5209. doi: 10.1002/sim.7047.

PMID:
27449759
5.

Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.

Sterling TR, Scott NA, Miro JM, Calvet G, La Rosa A, Infante R, Chen MP, Benator DA, Gordin F, Benson CA, Chaisson RE, Villarino ME; Tuberculosis Trials Consortium, the AIDS Clinical Trials Group for the PREVENT TB Trial (TBTC Study 26ACTG 5259) The investigators of the TB Trials Consortium and the AIDS Clinical Trials Group for the PREVENT TB Trial are listed in the Supplement, item 17..

AIDS. 2016 Jun 19;30(10):1607-15. doi: 10.1097/QAD.0000000000001098.

PMID:
27243774
6.

Prevalence of human immunodeficiency virus infection in a cohort of tuberculosis patients at Metema Hospital, Northwest Ethiopia: a 3 years retrospective study.

Tarekegne D, Jemal M, Atanaw T, Ebabu A, Endris M, Moges F, Tessema B, Deressa T.

BMC Res Notes. 2016 Mar 29;9:192. doi: 10.1186/s13104-016-2004-8.

7.

New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T Cells.

Abate G, Ruminiski PG, Kumar M, Singh K, Hamzabegovic F, Hoft DF, Eickhoff CS, Selimovic A, Campbell M, Chibale K.

Antimicrob Agents Chemother. 2015 Dec 7;60(3):1216-25. doi: 10.1128/AAC.01567-15.

8.

Analysis of HLA association among North Indian HIV-positive individuals co-infected with Mycobacterium tuberculosis.

Saikia B, Wanchu A, Mahakur S, Bind M, Sarkar K, Minz RW.

Lung India. 2015 Sep-Oct;32(5):449-52. doi: 10.4103/0970-2113.164166.

9.

Foreign-Born Status and Geographic Patterns of Tuberculosis Genotypes in Tarrant County, Texas.

Oppong JR, Denton CJ, Moonan PK, Weis SE.

Prof Geogr. 2007 Nov;59(4):478-491.

10.

Clinical manifestation and risk factors of tuberculosis infection in Malaysia: case study of a community clinic.

Shanmuganathan R, Subramaniam ID.

Glob J Health Sci. 2015 Jan 1;7(4):110-20. doi: 10.5539/gjhs.v7n4p110.

11.

Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells.

Lenz N, Schindler T, Kagina BM, Zhang JD, Lukindo T, Mpina M, Bang P, Kromann I, Hoff ST, Andersen P, Reither K, Churchyard GJ, Certa U, Daubenberger CA.

Clin Vaccine Immunol. 2015 Jul;22(7):688-96. doi: 10.1128/CVI.00092-15.

12.

Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease.

Huynh GH, Klein DJ, Chin DP, Wagner BG, Eckhoff PA, Liu R, Wang L.

BMC Med. 2015 Apr 21;13:88. doi: 10.1186/s12916-015-0341-4.

13.

Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis.

Chindelevitch L, Menzies NA, Pretorius C, Stover J, Salomon JA, Cohen T.

J R Soc Interface. 2015 May 6;12(106). pii: 20150146. doi: 10.1098/rsif.2015.0146.

14.

Comparative genomics of mycobacteria: some answers, yet more new questions.

Behr MA.

Cold Spring Harb Perspect Med. 2014 Nov 13;5(2):a021204. doi: 10.1101/cshperspect.a021204. Review.

15.

Diagnosis and treatment of latent tuberculosis infection: an update.

Person AK, Pettit AC, Sterling TR.

Curr Respir Care Rep. 2013 Dec;2(4):199-207.

16.

Latent tuberculosis infection: myths, models, and molecular mechanisms.

Dutta NK, Karakousis PC.

Microbiol Mol Biol Rev. 2014 Sep;78(3):343-71. doi: 10.1128/MMBR.00010-14. Review.

17.

Impact of GeneXpert MTB/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis: a hypothetical trial.

Chaisson LH, Roemer M, Cantu D, Haller B, Millman AJ, Cattamanchi A, Davis JL.

Clin Infect Dis. 2014 Nov 15;59(10):1353-60. doi: 10.1093/cid/ciu620.

18.

Factors associated with tuberculosis by HIV status in the Brazilian national surveillance system: a cross sectional study.

do Prado TN, Miranda AE, de Souza FM, Dias Edos S, Sousa LK, Arakaki-Sanchez D, Sanchez MN, Golub JE, Maciel EL.

BMC Infect Dis. 2014 Jul 28;14:415. doi: 10.1186/1471-2334-14-415.

19.

Transmission of tuberculosis in a South African community with a high prevalence of HIV infection.

Middelkoop K, Mathema B, Myer L, Shashkina E, Whitelaw A, Kaplan G, Kreiswirth B, Wood R, Bekker LG.

J Infect Dis. 2015 Jan 1;211(1):53-61. doi: 10.1093/infdis/jiu403.

20.

The importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission model.

Salje H, Andrews JR, Deo S, Satyanarayana S, Sun AY, Pai M, Dowdy DW.

PLoS Med. 2014 Jul 15;11(7):e1001674. doi: 10.1371/journal.pmed.1001674.

Items per page

Supplemental Content

Support Center